1.
Tamez-Pérez HE, SUMER G de E. Efficacy and safety of inicitial treatment with glimpeiride versus sitagliptin in type 2 diabetes. Rev Med Inst Mex Seguro Soc. 2015;53(2):142-148. Accessed November 16, 2026. https://revistamedica.imss.gob.mx/index.php/revista_medica/article/view/4